Use of Track One Prioritized Examination for Pharmaceutical Patents

JAMA Health Forum. 2024 Jul 5;5(7):e241886. doi: 10.1001/jamahealthforum.2024.1886.

Authors

S Sean Tu¹, William B Feldman^{2

3}

Affiliations

¹ West Virginia University College of Law, Morgantown.
² Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
³ Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

No abstract available

Plain language summary

This study examines the use of the Track One prioritized patent examination program by pharmaceutical manufacturers from 2011 to 2022.

MeSH terms

Drug Industry / legislation & jurisprudence
Humans
Patents as Topic* / legislation & jurisprudence
Pharmaceutical Preparations
United States

Substances

Pharmaceutical Preparations